European Journal of Clinical Microbiology

, Volume 6, Issue 5, pp 515–520 | Cite as

Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratories

  • European Study Group on Antibiotic Resistance


In 1984 the European Study Group on Antibiotic Resistance (ESGAR) consecutively collected gram-negative bacilli and staphylococci blood isolates and performed susceptibility testing with 11 antibiotics using the microdilution method. In all 2,578 isolates were collected: 68% gram-negative bacilli and 32% staphylococci. The MICs of ampicillin and cefazoline for the susceptible gram-negative bacilli were 1–8μg/ml; of piperacillin⩽0.5–4; of Sch 34343, cefotaxime, moxalactam, ceftazidime and aztreonam⩽0.5–2μg/ml; of cefoxitin, cefuroxime and cefamandole⩽0.5–8μg/ml. For susceptible staphylococci the MICs of cefazoline and cefuroxime were⩽0.5–1μg/ml, and of cefoxitin, moxalactam, ceftazidime and cefotaxime,⩽0.5–32 μg/ml. The resistance levels varied between laboratories and countries, being lower in Northern Europe. In clinical protocols on patients with gram-negative septicemia from whom cefazoline-resistant strains were isolated, cefotaxime was the beta-lactam most commonly used (12%). In protocols on patients with staphylococcal septicemia from whom gentamicin-resistant or cefazoline-resistant strains were isolated, the most commonly used beta-lactam was cloxacillin (6%).


Cefotaxime Ceftazidime Cefuroxime Cefazoline Piperacillin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Neu, H. C.: Beta-lactam antibiotics: structural relationships affecting in vitro activity and pharmacologic properties. Reviews of Infectious Diseases 1986, 8, Supplement 3: S237-S259.PubMedGoogle Scholar
  2. 2.
    Geddes, A. M.: Studies of beta-lactam antibiotics in systemic infections: some personal observations over 25 years. Reviews of Infectious Diseases 1986, 8, Supplement 3: S333-S349.PubMedGoogle Scholar
  3. 3.
    The Swedish Reference Group for Antibiotics: A revised system for antibiotic sensitivity testing. Scandinavian Journal of Infectious Diseases 1981, 13: 148–152.Google Scholar
  4. 4.
    Richmond, M. H., Sykes, R. B.: The beta-lactamases of gram-negative bacteria and their possible physiological role. Advances in Microbial Physiology 1973, 9: 31–88.PubMedCrossRefGoogle Scholar
  5. 5.
    Sykes, R. B., Mattew, M.: The beta-lactamases of gram-negative bacteria and their role in resistance to betalactam antibiotics. Journal of Antimicrobial Chemotherapy 1976, 2: 115–157.PubMedGoogle Scholar
  6. 6.
    Lindberg, F., Westman, L., Normark, S.: Regulatory components inCitrobacter freundii amp C beta-lactamase induction. Proceedings of the National Academy of Sciences of the United States of America 1985, 82: 4620–4624.PubMedGoogle Scholar
  7. 7.
    Dornbusch, K., Bengtsson, S., Bernander, S., Brorson, J. E., Forsgren, A., Holm, S., Malmborg, A. S., Nilsson, L., Mittermayer, H., Breitfellner, G., Rotter, M., Thiel, W., Mouton, R. P., Renkonen, O. V.: In vitro susceptibility to four aminoglycoside antibiotics among blood isolates from laboratories in four countries. Proceedings of 13th ICC, Vienna 1983, p. 87/50.Google Scholar
  8. 8.
    Ling, J., Chan, P. Y., Leung, Y. K., Ng, W. S.: Susceptibility of blood isolates to various antibiotics in particular to cephalosporins. Journal of Antimicrobial Chemotherapy 1983, 11: 473–480.PubMedGoogle Scholar
  9. 9.
    Ljungman, P., Malmborg, A. S., Nyström, B., Tillegård, A.: Bacteremia in a Swedish University Hospital. A oneyear prospective study in 1981 and a comparison with 1975–76. Infection 1984, 2–6.Google Scholar
  10. 10.
    Marier, R. L., Marinaccio, A. T., Sanders, C. V., Aldridge, K. E., Mitchell, J. W.: Susceptibility patterns of bacteria following therapy with piperacillin. Journal of Antimicrobial Chemotherapy 1982, 9, Supplement B: 85–88.PubMedGoogle Scholar
  11. 11.
    Jackson, G. G.: Antibiotic policies, practices and pressures. Journal of Antimicrobial Chemotherapy 1979, 5: 1–4.PubMedGoogle Scholar
  12. 12.
    McGowan Jr, J. E.: Antimicrobial resistance in hospital organisms and its relation to antibiotic usage. Reviews of Infectious Diseases 1983, 5: 1033–1048.PubMedGoogle Scholar
  13. 13.
    Wise, R., Phillips, I. (ed.): Sch 34343 — a new parenteral penem. Journal of Antimicrobial Chemotherapy 1985, 15, Supplement C: 1–238.Google Scholar
  14. 14.
    Norrby, R., Bergan, T., Holm, S., Normark, S. (ed.): Evaluation of new beta-lactam antibiotics. Reviews of Infectious Diseases 1986, 8, Supplement 3: S235–S370.Google Scholar
  15. 15.
    Hartman, B. J., Tomasz, A.: Expression of methicillin resistance in heterogenous strains ofS. aureus. Antimicrobial Agents and Chemotherapy 1986, 29: 85–92.PubMedGoogle Scholar
  16. 16.
    Kurpis, L., Schaberg, D., Fekety, R.: In-vitro activity of Sch 34343 against nosocomial pathogens: methicillin-resistant staphylococci, gentamicin-susceptible and -resistantStreptococcus faecalis, Clostridium difficile andBacteroides fragilis, Journal of Antimicrobial Chemotherapy 1985, 15, Supplement C: 133–136.PubMedGoogle Scholar
  17. 17.
    Ericsson, H. M., Sherris, J. C.: Antibiotic sensitivity testing. Report of an International Collaborative study. Acta Pathologica et Microbiologica Scandinavia (B) 1971, Supplement 217: 1–90.Google Scholar
  18. 18.
    European Study Group on Antibiotic Resistance: In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in 29 European laboratories. European Journal of Clinical Microbiology 1987, 6: 378–385.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1987

Authors and Affiliations

  • European Study Group on Antibiotic Resistance
    • 1
  1. 1.Department of Clinical MicrobiologyKarolinska HospitalStockholmSweden

Personalised recommendations